Elsevier

Heart, Lung and Circulation

Volume 30, Issue 10, October 2021, Pages 1425-1429
Heart, Lung and Circulation

Editorial
Myocarditis, Pericarditis and Cardiomyopathy After COVID-19 Vaccination☆

https://doi.org/10.1016/j.hlc.2021.07.011 Get rights and content

Keywords

mRNA vaccine
COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Myocarditis
Pericarditis
Cardiomyopathy
Cardiovascular disease
Australia
CSANZ
ANZSCTS

Cited by (0)

☆

Heart, Lung and Circulation’s Digital Collection of publications relating to COVID-19 is available at (www.heartlungcirc.org ). The COVID-19 Vaccination-Guidance on Myocarditis and Pericarditis After mRNA COVID-19 Vaccines can be assessed at: https://www.health.gov.au/sites/default/files/documents/2021/08/covid-19-vaccination-guidance-on-myocarditis-and-pericarditis-after-mrna-covid-19-vaccines_1.pdf . The guidance was jointly developed by the Australian Technical Advisory Group on Immunisation (ATAGI) and the Cardiac Society of Australia and New Zealand (CSANZ).

1

Basic Cardiovascular Science Editor, Heart, Lung and Circulation.

2

Commissioning Editor, Heart, Lung and Circulation.

3

Editor-in-Chief, Heart, Lung and Circulation.

View Abstract
© 2021 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.